Newz Drugs
Modern diuretic treatment D MACLEAN, G R TUDHOPE Diuretics are one of the most widely prescribed group of drugs with therapeutic indications in a diverse set of disorders.
Oedema
Thiazide diuretics form the mainstay of treatment for numerous conditions characterised by oedema, most notably congestive heart failure when there is a reduced glomerular filtration rate, increased aldosterone production, and increased sodium reabsorption from the renal tubules. Longstanding heart failure no longer responsive to a thiazide often responds dramatically to a loop diuretic, and a loop diuretic also rapidly relieves acute pulmonary oedema secondary to left ventricular failure. Resistant oedema, on the other hand, may respond favourably when diuretics that act on different parts of the renal tubule are given together-for example, thiazide plus a loop diuretic with or without the addition of an aldosterone antagonist. A thiazide or loop diuretic is prescribed together with spironolactone in the nephrotic syndrome and in cirrhosis of the liver complicated by ascites, both conditions being almost invariably associated with secondary hyperaldosteronism.
Thiazides and spironolactone are often prescribed, too, in some cases of recurrent, idiopathic cyclical oedema, particularly of the ankles, associated with water retention. In this disorder, which is most often seen in premenopausal women and especially at menstruation, diuretics may have an initial cosmetic effect, but long term benefit is hard to establish. Thiazides are also often inappropriately prescribed in managing chronic lymphoedema or chronic ankle oedema associated with varicose veins and poor venous return. Only in a few of these patients is the oedema easier to control as a result of using diuretics; adequate elastic support is more appropriate.
The requirement for diuretic treatment in managing oedema needs to be regularly reassessed in order not to exceed the necessary minimum dose of the least powerful diuretic that will suffice. When clinical judgment does not suflice, a useful means of measuring the loss of sodium and water is to observe the rate and extent of weight loss. Provided that the serum sodium concentration remains normal, 1 kg of water loss corresponds to 140-150 mmol(mEq) of associated sodium loss. Another useful assessment is to measure the 24 hour urinary sodium excretion: if this is below 10-20 mmol the diuretic treatment is inadequate, but if it is quite high (above 100 mmol) and body weight is not decreasing sodium excretion is satisfactory but sodium intake needs to be reduced. On the other hand, some patients are at risk of developing saline depletion with loss of tissue turgor, postural hypotension, and a rising serum urea concentration because of loss of interstitial fluid and a fall in plasma volume with poor renal perfusion. The diuretic dose in such patients may best be adjusted to allow mild ankle oedema in the evening, which will clear during the night in bed. Excessive diuresis will otherwise produce undue shrinkage of the plasma volume with resultant secondary hyperaldosteronism and hypokalaemia. Excessively rapid clearance of oedema also causes malaise.
Hypertension
Until now thiazides have remained one of the cornerstones of antihypertensive treatment in patients with normal renal function, but their long term metabolic consequences are beginning to cause increasing concern. Loop diuretics are generally less effective than thiazides in lowering the blood pressure in all but the more severe forms of hypertension and those associated with renal impairment. Small doses of thiazides lower blood pressure in both the erect and supine positions and only rarely cause postural hypotension. They are often used alone or are given together with other classes of antihypertensive drugs. They are particularly effective in patients with low renin hypertension-for example, many older patients and blacks-but their effect may not be apparent for two to three days and their maximum effect may not be reached for two to three weeks. The hypotensive effect of diuretics is not related solely to the initial fall in plasma volume but also to a later decrease in peripheral vascular resistance with long term treatment and possibly an effect on prostaglandin synthesis in the kidney. The antihypertensive effect of the thiazide diuretics is not much increased by increasing the dose-that is, they have a fairly flat dose-blood pressure response curve-but metabolic side effects become more troublesome with increasing dosage. disease during long term treatment, but in hypertension, at least, the benefit in terms of reduced incidence of stroke alone still outweighs these largely theoretical worries. None the less, blockers are increasingly seen as preferable first line drugs in managing essential hypertension. They, too, are not free from metabolic side effects, but adequate data are not yet available for comment. The most recently recognised side effect in young hypertensive men receiving long term thiazide treatment is a high incidence of impotence, which is reversible within a few weeks of withdrawing the drug. Thiazides, because they decrease sodium reabsorption in the proximal tubules indirectly, increase reabsorption of lithium with the consequent danger of inducing lithium toxicity in those with mania receiving long term treatment with lithium.
NEW DRUGS
Indapamide is chemically related to chlorthalidone and is claimed to lower blood pressure in most patients as effectively as thiazides but with little diuresis unless the dose exceeds 2-5 mg/day. Slight loss of weight associated with pronounced diuresis sometimes occurs in the elderly. The drug may have a useful role in managing hypertension in patients with prostatism or an unstable bladder, but it is not used to treat oedema. In contrast to the thiazides, indapamide has little or no apparent influence on concentrations of serum potassium, uric acid, glucose, or lipoproteins and produces only a modest rise in plasma renin activity; rashes may occur. Indapamide may, however, have an additional effect of decreasing the initial calcium current in arterial smooth muscle, and there has been a claim that resistant hypertension may be improved on long term use of the drug, presumably through a vasodilator action. In practice, no clear advantage of this expensive new drug over the established thiazides has yet been consistently shown, and further studies are required before its proper therapeutic role can be confidently defined.
Xipamide is a salicylate derivative which also structurally resembles chlorthalidone but it too has very different effects, being neither a thiazide nor a specific loop diuretic. It is marketed for use both in hypertension and for the "gentle" control of oedema in the elderly, but may be more potent than thiazides in both conditions. In hypertension once daily administration has comparable efficacy to that of beta-blockade over 24 hours without producing postural hypotension, but many elderly patients find its rather intense and prolonged diuresis disturbing. Although when it was first introduced in the United Kingdom side effects were reported as uncommon, hypokalaemia, sometimes profound and in part dose related, has emerged as the most worrying aspect of its long term use in some patients. Regular serum potassium estimations are therefore necessary if the drug is used long term, and the concurrent prescription of a potassium sparing diuretic often becomes desirable. Further work is again necessary with this compound before its role in modern diuretic treatment may be properly assessed.
LOOP DIURETICS
Loop diuretics (table) are rapidly and completely absorbed from the gut and consequently have an abrupt onset of action with the attainment of peak plasma concentrations at about 1 5 hours after ingestion. All are highly bound to plasma proteins. Bumetanide is excreted together with its metabolites in the urine. Frusemide is eliminated mainly unchanged in the tubules except in those patients with a glomerular filtration rate of below 10 ml/min, in whom gut excretion becomes important. Ethacrynic acid is extensively metabolised, and both the metabolites and the parent drug are excreted mainly in the urine.
Loop diuretics are powerful drugs because they inhibit sodium reabsorption from the ascending limb of the loop of Henle in the renal tubule where normally about 20" of the filtered sodium is reabsorbed, with, in addition, weak effects in the proximal tubule and the cortical diluting segment. Unlike the thiazides, Although potassium sparing diuretics are only weak diuretics, they potentiate the action of the thiazides or loop diuretics and are commonly used in combination to promote potassium retention. They act on the distal tubule, but only spironolactone and potassium canrenoate antagonise aldosterone. These two are particularly useful when there is excess circulating aldosterone, either primary (Conn's syndrome) or secondary, as in liver cirrhosis or the nephrotic syndrome, or occasionally in the oedema of resistant heart failure. In heart failure, when high dose frusemide-for example, 160 mg-proves inadequate, it is better to add spironolactone, especially if the 24 hour urinary sodium :potassium ratio is under 10, as increasing the loop diuretic dosage leads to loss of potassium rather than sodium in the urine. They are all expensive but maintain serum potassium concentrations much more reliably than does the use of low dose potassium supplements.
Canrenone, the active metabolite of spironolactone, has a much longer half life (about 10 hours) than the other two agents. While amiloride and triamterene may have a more rapid onset of effect, spironolactone may produce a greater potassium sparing effect. Since these drugs are used mainly because of their potassium sparing rather than their diuretic or antihypertensive properties, they are often prescribed as a combined thiazide-potassium sparer preparation-for instance, Aldactide, Moduretic, Dyazide.
Side effects
All these drugs promote potassium retention and therefore must be avoided or used with great caution when there is evidence of renal impairment because of the risk of hyperkalaemia and must never be prescribed together with potassium supplements. Tender nipples or painful gynaecomastia, menstrual irregularities, hirsuitism, and impotence are problems, particularly of large doses and long term treatment with spironolactone, and stem from the steroid configuration of the drug. Other less common side effects of these drugs include gastrointestinal upsets, especially nausea, epigastric discomfort, and diarrhoea, and mental confusion, chloasma, and rash. Potassium canrenoate causes nausea and vomiting especially in high dosage.
OTHER DIURETICS
Carbonic anhydrase inhibitors such as acetazolamide still have a use in glaucoma, albeit a diminishing one, and they have been tried in the prophylaxis of mountain sickness. Osmotic diuretics such as mannitol (Osmitrol) are commonly used to produce a forced diuresis in patients with cerebral oedema or self poisoning with drugs. The 20" solution of mannitol may also produce a useful diuresis in oedema resistant to other diuretics, and it is also used to prevent renal failure in jaundiced patients xindergoing surgery. Osmotic diuretics are contraindicated in renal or hepatic failure and in patients who have sustained a recent cerebral haemorrhage. It is less well known that isosorbide acts as a well tolerated orally active osmotic diuretic and has occasional use in lowering raised intracranial or intraocular pressure and in helping to clear hepatic ascites resistant to other measures.
POTASSIUM SUPPLEMENTS
Potassium chloride preparations are overprescribed since they are not usually necessary in patients receiving small doses of diuretics and in most young ambulant hypertensive patients. The need for taking measures to maintain the serum potassium concentration may be minimised by using the smallest dose of diuretic necessary to control oedema, by using those diuretics intermittently when possible, and by restricting unnecessary intake of salt. A more careful appraisal of the need for conserving potassium may, however, be needed in a few selected clinical conditions-for example, in the elderly receiving long term diuretic treatment because of their usually poor dietary intake of potassium; those taking digoxin or any other cardiac glycoside or who show evidence of arrhythmias, recent cardiac infarction, or severe angina because of the hazards of serious ventricular arrhythmias (discussed earlier); those receiving other drugs that cause hypokalaemia-for instance, steroids-and in diabetics. In these conditions the addition of a potassium sparing diuretic is preferable to the high amounts of supplementary potassium, such as 64 mmol/day, usually required, particularly because long term patient compliance with the number of tablets required is likely to falter. Similarly, the use of a potassium sparing diuretic is preferable in those taking another drug that interferes with ventricular repolarisation such as prenylamine, phenothiazines, or a tricyclic antidepressant, whenever the serum potassium concentration falls below 3 5 mmol/l. When supplements are used, they are more effective when used as prevention than to correct pre-existing hypokalaemia when a potassium sparing diuretic is nearly always preferable. Finally, the widespread practice of using combined diuretic-potassium supplement preparations is difficult to justify: not only is the supplement seldom necessary but most preparations contain far too little potassium to meet the needs of those who are hypokalaemic, and most of this is lost from the kidneys while they are under the influence of the diuretic. When potassium supplements are chosen, it would seem preferable to give the diuretic first thing in the morning and the potassium supplement in a sufficiently large dose much later in the day; compliance with the number of tablets required remains a problem. In hypertension the addition of a beta-blocker or captopril will often negate the need for either a potassium sparing diuretic or potassium supplementation. Illustrates the interaction and discusses the role of renal prostaglandins.
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What is the preferred nmethod of sterilisinlg vagitnal speculae in general practice, particularly with regard to herpes virus ? Can disposable plastic vaginal speculae be reused after appropriate sterilisationi ?
Mlost organisms, including the herpes virus, will be killed by 15 minutes' immersion in boiling water. Bacterial spores are resistant to boiling and require autoclaving for their eradication, but a small inoculum of anaerobic spore forming bacteria should not harm the healthy vagina, and boiling should be adequate for metal vaginal speculae in routine use. (Incidentally, a domestic piessure cooker can achieve the same result as an autoclave: after the cooker is brought to the boil an instrument should be steamed for 15 minutes at 15 lb/sq in-that is, the full pressure in an ordinary pressure cooker.) The difficulty with plastic speculae is finding an appropriate method of sterilisation. Most plastic speculae are not resistant to heat and therefore will warp or melt when boiled or autoclaved. 
